login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
ACELRX PHARMACEUTICALS INC (ACRX) Stock News
USA
- NASDAQ:ACRX -
US00444T2096
-
Common Stock
0.86
USD
+0.06 (+7.5%)
Last: 1/9/2024, 8:00:00 PM
0.8719
USD
+0.01 (+1.38%)
After Hours:
1/9/2024, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
ACRX Latest News, Press Relases and Analysis
All
Press Releases
3 months ago - By: The Motley Fool
- Mentions:
TLPH
Talphera Cuts Expenses 14 Percent
3 months ago - By: The Motley Fool
- Mentions:
TLPH
Talphera Cuts Costs and Speeds Trial
2 years ago - By: Seeking Alpha
AcelRx announces rebranding with name change to Talphera (NASDAQ:ACRX)
2 years ago - By: Talphera, Inc.
AcelRx Announces Rebranding With Name Change to Talphera, Inc.
2 years ago - By: Seeking Alpha
AcelRx Pharmaceuticals says CEO Angotti buys 10K shares in co (NASDAQ:ACRX)
2 years ago - By: Benzinga
- Mentions:
HSDT
HSTO
OGN
ALLR
5 Value Stocks In The Healthcare Sector
2 years ago - By: Benzinga
- Mentions:
DVAX
INVA
OGN
ALLR
Overview Of Value Stocks In The Healthcare Sector
2 years ago - By: AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals Announces Publication of Study Evaluating Anticoagulation Practices for Continuous Renal Replacement Therapy in the United States
2 years ago - By: InvestorPlace
- Mentions:
JTAI
NXTP
VIRC
PSTX
...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
2 years ago - By: Seeking Alpha
AcelRx Pharmaceuticals files for $150M mixed shelf (NASDAQ:ACRX)
2 years ago - By: AcelRx Pharmaceuticals, Inc.
AcelRx Reports Third Quarter 2023 Financial Results and Provides Corporate Update
2 years ago - By: AcelRx Pharmaceuticals, Inc.
AcelRx to Host KOL Panel Discussion on Current Anticoagulant Use in Dialysis and the Upcoming Niyad™ Clinical Study
2 years ago - By: AcelRx Pharmaceuticals, Inc.
AcelRx to Host Third Quarter 2023 Financial Results Call and Webcast on November 8, 2023
2 years ago - By: AcelRx Pharmaceuticals, Inc.
AcelRx Receives IDE Approval for Niyad and Advances to a Single Registration Study
2 years ago - By: Seeking Alpha
AcelRx CEO buys 10,000 shares (NASDAQ:ACRX)
2 years ago - By: AcelRx Pharmaceuticals, Inc.
AcelRx Reports Second Quarter 2023 Financial Results and Provides Corporate Update
2 years ago - By: AcelRx Pharmaceuticals, Inc.
AcelRx to Host Second Quarter 2023 Financial Results Call and Webcast on August 10, 2023
2 years ago - By: AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals Announces Closing of Previously Announced Private Placement Priced At-The-Market Under Nasdaq Rules
2 years ago - By: Seeking Alpha
AcelRx Pharmaceuticals launches ~$10M private placement of shares (NASDAQ:ACRX)
2 years ago - By: AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals Announces $10 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules
Please enable JavaScript to continue using this application.